dynorphin (1-8) has been researched along with Alzheimer Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berrettini, WH; Cohen, RM; Lawlor, BA; Martinez, RA; Molchan, SE; Sunderland, T; Tariot, PN; Vitiello, B | 1 |
1 other study(ies) available for dynorphin (1-8) and Alzheimer Disease
Article | Year |
---|---|
Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Depressive Disorder; Dynorphins; Female; Galanin; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Recall; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Neuropsychological Tests; Peptide Fragments; Peptides; Receptors, Opioid; Vasoactive Intestinal Peptide | 1991 |